Reducing Breathlessness With Dronabinol in COPD Patients

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: COPD, Breathlessness, Cannabis

In brief

This clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).

Key facts

Study ID
NCT06473701
Run by
Vejle Hospital
People needed
30
Starts
2025-02-26
Expected to finish
2026-10-01
Last updated by the study team
2026-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.